Prosecution Insights
Last updated: October 02, 2026
Application No. 18/703,459

WATER TREATMENT SYSTEM AND WATER TREATMENT METHOD

Non-Final OA §103
Filed
Apr 22, 2024
Priority
Oct 25, 2021 — JP 2021-173932 +2 more
Examiner
KIM, SUN U
Art Unit
Tech Center
Assignee
Organo Corporation
OA Round
1 (Non-Final)
78%
Grant Probability
Favorable
1-2
OA Rounds
4m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
770 granted / 985 resolved
+18.2% vs TC avg
Moderate +12% lift
Without
With
+11.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
48 currently pending
Career history
1011
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
45.1%
+5.1% vs TC avg
§102
23.9%
-16.1% vs TC avg
§112
19.2%
-20.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 985 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Species I (claims 1-9) in the reply filed on 8/27/2026 is acknowledged. Claims 11-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected species, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 8/27/2026. Claims 1-10 are examined in this office action. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1 and 6-10 are rejected under 35 U.S.C. 103 as being unpatentable over Japanese Patent No. 6799657 B1 to Keisuke et al. (hereinafter “Keisuke”) in view of Japanese Patent Publication No. 2013-202581 A (Seiichi). Regarding claims 1 and 10, Keisuke teaches a water treatment system (an ultrapure water production system 2 in fig. 1) comprising at least one reverse osmosis membrane device (22A, 22B) and at least one electrodeionization device (25) that is located downstream of the at least one reverse osmosis membrane device (22A, 22B), the system comprising: a first heat exchanger (21) that is located upstream of the at least one reverse osmosis membrane device (22A, 22B) and that adjusts the temperature of the water supplied to the at least one reverse osmosis membrane device (22A, 22B) according to the temperature of a raw water supplied to the water treatment system; and a second heat exchanger (24) that is located between the at least one reverse osmosis membrane device (22A, 22B) and the at least one electrodeionization device (25) and that cools the water supplied to the electrodeionization device (25) (see fig. 1; paragraphs [0009]-[0010]). Claims 1 and 10 differ from Keisuke in reciting that one of the first heat exchanger and the second heat exchanger is an internal heat exchanger that exchanges heat inside the water treatment system, and the other is an external heat exchanger that exchanges heat with outside of the water treatment system. Seiichi teaches an ultrapure water production device wherein a front-stage heat exchanger 45 (internal heat exchanger) using return water and a rear-stage heat exchanger 46 (external heat exchanger) using steam are described as heat exchangers (see paragraphs [0025], [0026], fig. 1-2). It would have been obvious to a person of ordinary skill in the art to use one of the first and second heat exchangers as the internal heat exchanger and the other as an external heat exchanger in the ultrapure water production system of Keisuke as suggested by Seiichi (see paragraphs [0025], [0026], fig. 1-2). Regarding claim 6, Keisuke teaches a subsystem (3) located between the electrodeionization device (25) and a point of use (8), wherein: the subsystem (3) includes a water treatment device (31-35) that further treats the treated water of the electrodeionization device (25), and a second recirculation line (L3) that returns the treated water of the water treatment device (31-35) to upstream of the water treatment device (31-35)(see fig. 1; paragraphs [0009], [0021]). Regarding claim 7, Keisuke teaches that the temperature of the water to be treated and supplied to the reverse osmosis membrane device (22A) is adjusted to about 25°C by the first heat exchanger 21 (see paragraph [0010]). Regarding claim 8, Keisuke teaches that the temperature of the water supplied to the electrodeionization device (25) is adjusted by the second heat exchanger (24) 10-23°C (see paragraph [0016]). Regarding claim 9, Keisuke teaches that the raw water contains silica and boron, the silica concentration of the water treated by the reverse osmosis membrane device is 100 ppb or less, and the boron concentration is 50 ppb or less (see Table 1 in paragraph [0028]). Allowable Subject Matter Claims 2-5 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN KIM whose telephone number is (571)272-1142. The examiner can normally be reached Maxi Flex. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, INSUK BULLOCK can be reached at 571-272-5954. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /John Kim/Primary Examiner, Art Unit 1772 JK 9/21/26
Read full office action

Prosecution Timeline

Apr 22, 2024
Application Filed
Sep 24, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746313
PERITONEAL DIALYSIS CYCLER USING MICROPUMP
3y 8m to grant Granted Sep 29, 2026
Patent 12746314
AUTOMATED PERITONEAL DIALYSIS CYCLER HAVING GRAVIMETRIC CONTROL
3y 1m to grant Granted Sep 29, 2026
Patent 12734292
BALL JOINT-STYLE, NON-FIXED COUPLING BETWEEN A PUSHER PLATE AND PLUNGER IN A SYRINGE BARREL
3y 2m to grant Granted Sep 15, 2026
Patent 12728188
DEVICE AND METHOD FOR VERIFYING THE CORRECT SETUP OF A BLOOD TREATMENT APPARATUS
3y 3m to grant Granted Sep 08, 2026
Patent 12730040
CHELATOR BASED ELUENTS FOR SOLID PHASE EXTRACTION OF PHOSPHORYLATED COMPOUNDS
2y 4m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
78%
Grant Probability
90%
With Interview (+11.5%)
2y 9m (~4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 985 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month